ReviewClinical & translational immunology2019

Chimeric antigen receptors designed to overcome transforming growth factor-β-mediated repression in the adoptive T-cell therapy of solid tumors.

Jordan Hartley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.